Loading clinical trials...
Loading clinical trials...
Multicenter, Randomized, Double-Masked, Placebo-Controlled, Parallel Group Phase 2 Trial Evaluating the Safety and Efficacy of Pilocarpine Ophthalmic Topical Cream BID for the Treatment of Presbyopia
Conditions
Interventions
Pilocarpine Ophthalmic Topical Cream, Dose 1
Pilocarpine Ophthalmic Topical Cream, Dose 2
+2 more
Locations
10
United States
Glaukos Investigator
Chandler, Arizona, United States
Glaukos Investigator
Sun City, Arizona, United States
Glaukos Investigator
Glendale, California, United States
Glaukos Investigator
Newport Beach, California, United States
Glaukos Investigator
Petaluma, California, United States
Glaukos Investigator
Louisville, Kentucky, United States
Start Date
January 3, 2022
Primary Completion Date
September 6, 2022
Completion Date
September 6, 2022
Last Updated
September 1, 2023
NCT06060041
NCT03135327
NCT07051720
NCT06948357
NCT06869044
NCT04465409
Lead Sponsor
Glaukos Corporation
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions